Crescent Biopharma, Inc. SEC filings CBIO
Crescent Biopharma, Inc. has 676 filings in SEC EDGAR's recent list, going back to Jul 10, 2003. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 30, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 15, 2026 |
| S-8 | Employee stock plan registration | Sep 18, 2026 | — |
| EFFECT | Filing | Jul 31, 2026 | — |
| POS AM | Filing | Jul 30, 2026 | — |
| 424B3 | Prospectus | Jul 30, 2026 | — |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 15, 2026 | Jul 14, 2026 |
| 424B5 | Prospectus supplement | Jul 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jul 14, 2026 | Jul 14, 2026 |
| 424B5 | Prospectus supplement | Jul 14, 2026 | — |
| EFFECT | Filing | Jul 10, 2026 | — |
| S-3 | Shelf registration | Jul 1, 2026 | — |
| 424B3 | Prospectus | Jun 22, 2026 | — |
| 10-Q/A | Amended quarterly report | Jun 22, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| 10-Q | Quarterly report | Apr 29, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 2, 2026 |
| 424B3 | Prospectus | Mar 17, 2026 | — |
| EFFECT | Filing | Mar 3, 2026 | — |
| POS AM | Filing | Mar 3, 2026 | — |
| 424B3 | Prospectus | Feb 26, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Jan 15, 2026 | — |
| 424B3 | Prospectus | Jan 15, 2026 | — |
| CORRESP | Letter to the SEC | Jan 13, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2026 | — |
| S-1 | Registration statement | Jan 7, 2026 | — |
| S-4 POS | Filing | Dec 12, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 4, 2025 | Dec 2, 2025 |
| S-8 | Employee stock plan registration | Nov 6, 2025 | — |
| 8-A12B/A | Filing | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jul 31, 2025 | Jul 29, 2025 |
| 10-Q | Quarterly report | Jul 31, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 18, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure, Other events
|
Jun 6, 2025 | Jun 5, 2025 |
| 425 | Filing | May 30, 2025 | — |
| 8-K |
Current report
Other events
|
May 30, 2025 | May 30, 2025 |
| 425 | Filing | May 29, 2025 | — |
| SEC STAFF LETTER | Filing | May 14, 2025 | — |
| EFFECT | Filing | May 14, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 424B3 | Prospectus | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 13, 2025 | — |
| CORRESP | Letter to the SEC | May 12, 2025 | — |
| S-4/A | Filing | May 12, 2025 | — |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| S-4/A | Filing | Apr 29, 2025 | — |
| 425 | Filing | Apr 29, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 29, 2025 | Apr 28, 2025 |
| CORRESP | Letter to the SEC | Apr 28, 2025 | — |
| 425 | Filing | Apr 28, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2025 | — |
| CORRESP | Letter to the SEC | Apr 4, 2025 | — |
| CORRESP | Letter to the SEC | Apr 4, 2025 | — |
| S-4/A | Form s-4/a | Apr 4, 2025 | — |
| 425 | Filing | Apr 3, 2025 | — |
| 425 | Filing | Apr 3, 2025 | — |
| SEC STAFF LETTER | Filing | Mar 18, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| 425 | Filing | Feb 28, 2025 | — |
| 425 | Filing | Feb 27, 2025 | — |
| 425 | Filing | Feb 25, 2025 | — |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Feb 25, 2025 | Feb 19, 2025 |
| S-4 | Registration for a merger or exchange | Feb 18, 2025 | — |
| 425 | Filing | Feb 14, 2025 | — |
| 8-K |
Current report
Material agreement
|
Feb 14, 2025 | Feb 14, 2025 |
| 10-K | Annual report | Feb 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2025 | Jan 29, 2025 |
| DEFA14A | Additional proxy material | Jan 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Listing notice
|
Dec 26, 2024 | Dec 19, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Nov 7, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2024 | Nov 7, 2024 |
| DEFA14A | Additional proxy material | Oct 29, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure, Other events
|
Oct 29, 2024 | Oct 28, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Jul 30, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Listing notice
|
Jun 26, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2024 | Jun 4, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 2, 2024 | May 1, 2024 |
| ARS | Annual report to shareholders | Apr 1, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 1, 2024 | May 1, 2024 |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| 8-K |
Current report
Results of operations
|
Mar 27, 2024 | Mar 27, 2024 |
| 10-K | Annual report | Mar 27, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 22, 2024 | May 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 1, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 2, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2023 | Nov 3, 2023 |
| 10-Q | Quarterly report | Nov 3, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2023 | May 19, 2023 |
| 8-K |
Current report
Results of operations
|
May 3, 2023 | May 3, 2023 |
| 10-Q | Quarterly report | May 3, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 21, 2023 | Apr 19, 2023 |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 21, 2023 | May 19, 2023 |
| S-8 | Employee stock plan registration | Mar 29, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2023 | Feb 21, 2023 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 4, 2022 | Oct 4, 2022 |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 3, 2022 | May 31, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 20, 2022 | May 18, 2022 |
| 424B5 | Prospectus supplement | Apr 28, 2022 | — |
| 10-Q | Quarterly report | Apr 28, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2022 | Apr 28, 2022 |
| EFFECT | Filing | Apr 22, 2022 | — |
| CORRESP | Letter to the SEC | Apr 20, 2022 | — |
| DEF 14A | Proxy statement | Apr 11, 2022 | May 18, 2022 |
| UPLOAD | Letter from the SEC | Mar 10, 2022 | — |
| S-3 | Shelf registration | Mar 4, 2022 | — |
| S-8 | Employee stock plan registration | Mar 3, 2022 | — |
| 8-K |
Current report
Results of operations
|
Mar 3, 2022 | Mar 3, 2022 |
| 10-K | Annual report | Mar 3, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 27, 2022 | Jan 21, 2022 |
| 10-Q | Quarterly report | Nov 2, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2021 | Nov 2, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
|
Aug 5, 2021 | Jul 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2021 | May 18, 2021 |
| 8-K |
Current report
Results of operations
|
May 3, 2021 | May 3, 2021 |
| 10-Q | Quarterly report | May 3, 2021 | Mar 31, 2021 |
| DEF 14A | Proxy statement | Apr 5, 2021 | May 5, 2021 |
| S-8 | Employee stock plan registration | Mar 2, 2021 | — |
| 8-K |
Current report
Results of operations
|
Mar 2, 2021 | Mar 2, 2021 |
| 10-K | Annual report | Mar 2, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 23, 2021 | Feb 19, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2020 | Nov 6, 2020 |
| 10-Q | Quarterly report | Nov 6, 2020 | Sep 30, 2020 |
| 424B5 | Prospectus supplement | Oct 7, 2020 | — |
| 8-K |
Current report
Material agreement
|
Oct 7, 2020 | Oct 7, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2020 | Jul 31, 2020 |
| 10-Q | Quarterly report | Jul 31, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2020 | May 22, 2020 |
| DEFA14A | Additional proxy material | May 8, 2020 | — |
| 8-K |
Current report
Results of operations
|
May 1, 2020 | May 1, 2020 |
| 10-Q | Quarterly report | May 1, 2020 | Mar 31, 2020 |
| DEF 14A | Proxy statement | Apr 16, 2020 | May 22, 2020 |
| S-8 | Employee stock plan registration | Feb 28, 2020 | — |
| 8-K |
Current report
Results of operations, Other events
|
Feb 28, 2020 | Feb 28, 2020 |
| 10-K | Annual report | Feb 28, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Agreement ended
|
Feb 10, 2020 | Feb 5, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 7, 2020 | Jan 2, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 21, 2019 | Nov 21, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Other events
|
Aug 5, 2019 | Aug 2, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2019 | Aug 1, 2019 |
| 10-Q | Quarterly report | Aug 1, 2019 | Jun 30, 2019 |
| EFFECT | Filing | May 28, 2019 | — |
| CORRESP | Letter to the SEC | May 23, 2019 | — |
| UPLOAD | Letter from the SEC | May 23, 2019 | — |
| 8-K |
Current report
Shareholder vote results
|
May 17, 2019 | May 17, 2019 |
| S-3 | Shelf registration | May 17, 2019 | — |
| 10-Q | Quarterly report | May 2, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 2, 2019 | May 2, 2019 |
| DEF 14A | Proxy statement | Apr 10, 2019 | May 17, 2019 |
| S-8 | Employee stock plan registration | Mar 6, 2019 | — |
| 8-K |
Current report
Results of operations
|
Mar 6, 2019 | Mar 6, 2019 |
| 10-K | Annual report | Mar 6, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 5, 2019 | Mar 1, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 28, 2018 | Nov 27, 2018 |
| 10-Q | Quarterly report | Nov 2, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2018 | Nov 2, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2018 | Aug 9, 2018 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2018 | Jul 23, 2018 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2018 | May 18, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Results of operations
|
May 3, 2018 | May 3, 2018 |
| DEF 14A | Proxy statement | Apr 13, 2018 | May 18, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 21, 2018 | Mar 20, 2018 |
| 424B5 | Prospectus supplement | Mar 21, 2018 | — |
| 424B5 | Prospectus supplement | Mar 19, 2018 | — |
| S-8 | Employee stock plan registration | Mar 6, 2018 | — |
| 10-K | Annual report | Mar 6, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2018 | Mar 6, 2018 |
| 10-Q | Quarterly report | Nov 8, 2017 | Sep 30, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2017 | Nov 8, 2017 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1253689
- Former names
- GLYCOMIMETICS INC (until Jun 23, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.